TORONTO, March 11, 2019 /CNW/ - Trulieve Cannabis (OTC: TCNNF & CNSX: TRUL) ("Trulieve" or the "Company"), a leading and top-performing cannabis company in the United States, today announces that Benjamin Atkins has resigned from its Board of Directors effective immediately for personal reasons. Mr. Atkins is one of the initial investors in the company and Trulieve is grateful for his contributions to the company and wishes him well in his future endeavors.

"I am very pleased to have been a part of Trulieve from its first days, seeing it grow to become a leading provider in Florida, and now entering new states," stated Mr. Atkins. "I wish management and the whole Trulieve team continued success."

About Trulieve

Trulieve Cannabis Corp. is a vertically integrated "seed to sale" company and is the first and largest fully licensed cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California and Massachusetts.

Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL.

To learn more about Trulieve, visit www.Trulieve.com.

Forward-Looking Statements

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of Trulieve. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of Trulieve to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although Trulieve believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, Trulieve assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable law.

SOURCE Trulieve Cannabis Corp.

For further information: Kevin Darmody, Director, Investor Relations, (850) 480-7955, [email protected]; Victoria Walker, Director of Marketing & Community Relations, (704) 773-3446, [email protected]